Ducray Melascreen Anti-Brown Spots Concentrate 30ml
This item is currently being restocked at our warehouse. Please subscribe to our availability alert system to be notified when it becomes available.
|
6 to 10 days delivery from $17.76 |
|
2 to 3 days delivery from $26.66 |
Ducray Melascreen Anti-Brown Spots Concentrate 30ml is a cream based on the combination of a trio of highly concentrated active ingredients:
- azelaic acid and hesperidine methylchalcone, with their complementary depigmenting action, regulate the overproduction of melanin responsible for the formation of stains,
- glycolic acid promotes the elimination of dead cells on the surface of the epidermis to reduce the intensity of stains.
This light texture cream offers a non-greasy, non-sticky finish.
Dermatologically tested. Non-comedogenic.
Made in France.
Apply twice daily to the face, neck and/or décolleté. For optimal results, apply for at least 1 month.
Avoid sun exposure or apply sun protection in addition.
Avoid contact with eyes.
Water (Aqua), Azelaic Acid, Caprylic/Capric Triglyceride, Squalane, Propanediol, Glycerin, Glycolic Acid, Glyceryl Stearate, Sodium Hydroxide, Cetearyl Alcohol, Arachidyl Alcohol, Arachidyl Glucoside, Behenyl Alcohol, Benzoic Acid, Cetearyl Glucoside, Helianthus Annuus (Sunflower) Seed Oil (Helianthus Annuus Seed Oil), Hesperidin Methyl Chalcone, Sclerotium Gum, Sodium Chloride, Tocopherol.
| EAN Code | 3282770389197 |
| Form | Cream |
| Presentation | Pump Bottle |
| Contents | 30ml |
Discover the Ducray brand
Ducray Laboratories propose a range of products dedicated to health and beauty of skin and hair.
Thanks to a permanent scientific watch, Ducray Dermatological Laboratories are looking for the most adapted answer to hair and cutaneous needs. They associate to each product, one or several active ingredients, rigorously selected to be the most 'pertinent', both for efficiency and tolerance.
Moreover, a special attention is given to fragrances and textures, in order to ensure the best comfort during application.
